Therapeutic Discovery RSK 2 Ser 227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
暂无分享，去创建一个
M. Taniwaki | S. Iida | Y. Shiotsu | S. Horiike | J. Kuroda | Y. Shimura | M. Yamamoto-Sugitani | M. Ri | Yosuke Matsumoto | Y. Chinen | Tsutomu Kobayashi | H. Nagoshi | M. Kiyota | R. Nakayama | N. Sakamoto | S. Mizutani | Natsumi Sakamoto | Ryuko Nakayama | Mio Yamamoto‐Sugitani | Hisao Nagoshi